Curated by Wilson Sonsini's Michael Hostetler and Dan Koeppen, LaunchBio’s NextGen VC Forum is the premiere event for venture capital associates to expand their skills and expertise while growing their network. The half-day forum includes a networking breakfast, three one-hour sessions and lunch. Attendance at NextGen VC Forum is by invitation only; if interested, please contact your firm’s senior partners.
Join Michael, Dan, and LaunchBio for a half-day program VC associates won't want to miss!
PANEL 1 - ON YOUR TERMS: NEGOTIATING TERM SHEETS
Life science venture capitalists must be familiar with the key terms and provisions in term sheets when negotiating with startups. They should also have a solid understanding of the negotiation process and be able to effectively negotiate and protect their interests while also ensuring that the startup is able to successfully reach its goals. Gain clarity and depth in understanding term sheets and the negotiation process.
PANEL 2 - ASSESSING THE RISK - LEVERAGING IP DILIGENCE
To make informed investment decisions and assess the risks and opportunities effectively, life science venture capitalists must understand the importance of conducting thorough IP diligence when evaluating potential investment opportunities in this space. We’ll cover IP due diligence, patents, freedom-to-operate, IP licensing and IP litigation so venture capitalists can confidently know their assets.
PANEL 3 - ALL ABOARD! UNDERSTANDING BOARD GOVERNANCE
To represent their interests, protect their investments, and ensure the company is being managed effectively, life science venture capitalists should be well versed in board governance. Dive into representation, oversight, alignment, board dynamics, compliance and more. Life science venture capitalists will be able to immediately apply new knowledge and skills for better governance, ultimately maximizing their investments.
Curated by:
Juliana Campbell
jcampbell@wsgr.comChristina represents public and private technology and life sciences companies, as well as financial institutions, in a wide range of corporate transactions, including IPOs, follow-on and secondary offerings, private financings, and M&A.
Kassandra K. Castillo practices corporate and securities law in the San Diego office of Wilson Sonsini Goodrich & Rosati, where she serves as outside general counsel and advises life sciences and technology companies at all stages of development. She works closely with entrepreneurs to counsel them through initial company formation issues, day-to-day corporate governance matters, venture capital financing transactions, and liquidity events. She also counsels venture capital funds on structuring and executing investment transactions and managing their existing portfolio companies.
Julia Minitti is a partner in Wilson Sonsini's patent and innovation strategies practice and currently serves as co-chair of the firm's Hiring Committee.
Alex focuses on representing clients in the biotechnology, pharmaceutical, medical device, diagnostic, and digital health industries.
Amy is a leader of Wilson Sonsini’s Delaware office and governance practice.